Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 4Completed 4Recruiting 3Active not recruiting 3Withdrawn 1Not yet recruiting 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 4Urinary Bladder Neoplasms 3Non-Muscle Invasive Bladder Neoplasms 3Appendiceal Neoplasms 2Urothelial Carcinoma Ureter 1Peritoneal Neoplasms 1Peritoneal Diseases 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Carcinoma, Transitional Cell 1Carcinoma in Situ 1

Interventions

Nivolumab 2toripalimab 1pemigatinib 1pembrolizumab 1enfortumab vedotin 1disitamab vedotin 1avelumab 1Specimen Handling 1Single Person 1Radiotherapy 1Mitomycin 1Magnetic Resonance Spectroscopy 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Transitional Cell × Mitomycin × Clear all
NCT07189793 2025-09-24

OHAI-NMIBC-01

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Not yet recruiting
106 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡